DOC — Healthpeak Properties, Inc. stock price, charts and financials

QT61Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (NYSE: DOC) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
21.03
-0.38-1.76%
DOCQT61Healthpeak Properties, Inc.·NYSE
21.03-1.76%
News
Down 1.8% — Healthpeak Properties Q2 Earnings Call Highlights (marketbeat.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
IndexS&P 500P/E61.17EPS (ttm)0.35Insider Own0.91%Shs Outstand689.42MPerf Week-1.92%
Market Cap14.76BForward P/E176.32EPS next Y0.12Insider Trans-0.18%Shs Float686.69MPerf Month-0.74%
Enterprise Value13.13BPEG-EPS next Q-Inst Own-Short Float3.49%Perf Quarter8.90%
Income253.88MP/S5.00EPS this Y13.96%Inst Trans-Short Ratio2.81Perf Half Y28.36%
Sales2.95BP/B1.88EPS next Y-66.70%ROA1.17%Short Interest23.95MPerf YTD33.15%
Book/sh-P/C9.90EPS next 5Y-ROE3.30%52W High22.54 -6.71%Perf Year27.06%
Cash/sh-P/FCF27.69EPS past 3/5Y-52.28% -33.52%ROIC23.67%52W Low15.42 36.37%Perf 3Y-0.93%
Dividend Est.0.41 (1.93%)EV/EBITDA7.37Sales past 3/5Y11.06% 11.41%Gross Margin2.53%Volatility2.86% 2.21%Perf 5Y-42.09%
Dividend TTM1.22 (5.80%)EV/Sales4.45EPS Y/Y TTM-11.11%Oper. Margin17.61%ATR (14)0.52Perf 10Y-45.13%
Dividend Ex-DateAug 17, 2026Quick Ratio1.84Sales Y/Y TTM6.37%Profit Margin8.60%RSI (14)46.16Recom2.49
Dividend Gr. 3/5Y-9.76% -10.88%Current Ratio1.84EPS Q/Q-39.13%SMA20-2.83%Beta0.98Target Price22.25
Payout416.99%Debt/Eq0.00Sales Q/Q7.11%SMA501.25%Rel Volume0.52Prev Close21.41
Employees411LT Debt/Eq1.26EarningsOct 22SMA20016.94%Avg Volume7.72MPrice21.03
IPO DateMay 23, 1985Option/ShortYes / YesEPS/Sales Surpr.430.66% 6.36%Net Debt/EBITDA-0.91Volume4,035,462Change-1.76%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedCantor FitzgeraldOverweight$20$23
Jul-15-26ReiteratedWells FargoEqual Weight$18$22
Jul-07-26DowngradeBarclaysOverweightEqual Weight$20$23
Jul-06-26ReiteratedMizuhoOutperform$24
Jun-15-26ReiteratedBMO CapitalOutperform$24
Jun-11-26DowngradeMorgan StanleyOverweightEqual Weight$20$22
May-27-26ReiteratedScotiabankSector Perform$21
May-22-26ReiteratedMorgan StanleyOverweight$18$20
May-13-26ReiteratedUBSNeutral$17$19
Apr-28-26ReiteratedMorgan StanleyOverweight$21$18
Latest News
Aug-08-26
Aug-07-26
Aug-06-26
Aug-05-26
Aug-04-26
Jul-30-26
Jul-29-26
Jul-26-26
Jul-26-2609:00AM
Jul-25-26
Jul-21-26
Company

Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,9502,8232,700
Cost of Goods Sold Incl. D&A2,8752,1881,075
Gross Profit756351,626
Selling, General and Administrative Excl. Other929097
Research and Development
000
Other Operating Expense-53601,057
Operating Income520544471
Interest Expense337305280
Unusual Expense
Non-Operating Income (Expense)96-12981
Net Income Before Taxes279110272
Income Taxes494
Consolidated Net Income25471243
Net Income From Continuing Operations275101267
Net Income25471243
EPS (Recurring)0.350.100.36
EPS (Basic, Before Extraordinaries)0.350.100.36
EPS (Diluted)0.350.100.36
EBITDA1,7821,4741,611
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio60.09160.8056.31
Price To Sales Ratio4.923.965.08
Gross Margin2.5422.4960.22
Operating Margin17.6319.2717.44
Net Margin8.612.529.00
Shares Outstanding690696676
Market Capitalization14,51211,19213,703
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$23.88$21.59$19.30$17.01$14.72 Close Price0.00K53.44K106.87K160.31K213.74KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Bohn Scott RCDO and Head of LabMay 12 '26Sale19.4510,989213,7407,636May 13
Thomas John TDirectorAug 06 '25Buy17.051,45024,730810,016Aug 06
Brinker Scott MPresident and CEOAug 04 '25Buy16.831,49025,077211,906Aug 04
Brinker Scott MPresident and CEOJul 31 '25Buy17.062,93049,986210,416Jul 31
Brinker Scott MPresident and CEOJul 28 '25Buy17.402,87349,990207,486Jul 29
Thompson Tommy GDirectorMay 28 '25Buy17.275,77799,769144,290May 28
Thompson Tommy GDirectorMay 09 '25Buy17.365,70098,974138,513May 12
Brinker Scott MPresident and CEOMay 09 '25Buy17.392,75047,823204,613May 12
Lias-Booker AvaDirectorApr 29 '25Buy17.835,00089,15035,561Apr 29
Thomas John TDirectorApr 28 '25Buy17.844,20074,928813,566Apr 28
Sandstrom Katherine MDirectorApr 28 '25Buy17.6511,288199,23356,268Apr 28
Lewis Sara GrootwassinkDirectorApr 28 '25Buy17.666,000105,9389,000Apr 28
SHELLEY-KESSLER PAMELADirectorApr 28 '25Buy17.612,83849,9913,965Apr 28
Brinker Scott MPresident and CEOApr 28 '25Buy17.6811,337200,438201,863Apr 28
Lewis Sara GrootwassinkDirectorMar 04 '24Buy16.7118,000300,78022,000Mar 04
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.